2023


  1. Saalbach A, Anderegg U, Wendt R, Beige J, Bachmann A, Klöting N, Blüher M, Zhang MZ, Harris RC, Stumvoll M, Tönjes A, Ebert T (2023). Antifibrotic Soluble Thy-1 Correlates with Renal Dysfunction in Chronic Kidney Disease. Int J Mol Sci, 24, 1-13.
     
  2. Schürfeld R, Sandner B, Hoffmann A, Klöting N, Baratashvili E, Nowicki M, Paeschke S, Kosacka J, Kralisch S, Bachmann A, Frille A, Dietel A, Stolzenburg JU, Blüher M, Zhang MZ, Harris RC, Isermann B, Stumvoll M, Tönjes A, Ebert T (2023). Renal function is a major predictor of circulating acyl-CoA-binding protein/diazepam-binding inhibitor. Front Endocrinol (Lausanne), 14, 1-10.
     
  3. Lehmann C, Pehnke S, Weimann A, Bachmann A, Dittrich K, Petzold F, Fürst D, de Fallois J, Landgraf R, Henschler R, Lindner TH, Halbritter J, Doxiadis I, Popp B, Münch J (2023). Extended genomic HLA typing identifies previously unrecognized mismatches in living kidney transplantation. Front Immunol, 14, 1094862.
     
  4. Lehmann C, Pehnke S, Weimann A, Bachmann A, Dittrich K, Petzold F, Fürst D, de Fallois J, Landgraf R, Henschler R, Lindner TH, Halbritter J, Doxiadis I, Popp B, Münch J (2023). Extended genomic HLA typing identifies previously unrecognized mismatches in living kidney transplantation. Front Immunol, 14, 1094862.
     


    5. 2020


  5. Tönjes A, Hoffmann A, Kralisch S, Qureshi AR, Klöting N, Scholz M, Schleinitz D, Bachmann A, Kratzsch J, Nowicki M, Paeschke S, Wirkner K, Enzenbach C, Baber R, Beige J, Anders M, Bast I, Blüher M, Kovacs P, Löffler M, Zhang MZ, Harris RC, Stenvinkel P, Stumvoll M, Fasshauer M, Ebert T (2020). Pro-neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease. Eur J Endocrinol, 183, 233-244.
     


    6. 2019


  6. Ottlewski I, Munch J, Wagner T, Schonauer R, Bachmann A, Weimann A, Hentschel J, Lindner TH, Seehofer D, Bergmann C, Jamra RA, Halbritter J (2019). Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease. Kidney Int, 96, 222-230.
     
  7. Petzold F, Bachmann A, Bergmann C, Helmchen U, Halbritter J (2019). Retrospective genetic analysis illustrates the spectrum of autosomal Alport syndrome in a case of living-related donor kidney transplantation. BMC Nephrol, 20, 340-345.
     
  8. Eder M, Schwarz C, Kammer M, Jacobsen N, Stavroula ML, Cowan MJ, Chongkrairatanakul T, Gaston R, Ravanan R, Ishida H, Bachmann A, Alvarez S, Koch M, Garrouste C, Duffner UA, Cullis B, Schaap N, Medinger M, Sorensen SS, Dauber EM, Bohmig G, Regele H, Berlakovich GA, Wekerle T, Oberbauer R (2019). Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis. Am J Transplant, 19, 475-487.
     
  9. Ziemann M, Altermann W, Angert K, Arns W, Bachmann A, Bakchoul T, Banas B, von Borstel A, Budde K, Ditt V, Einecke G, Eisenberger U, Feldkamp T, Gorg S, Guthoff M, Habicht A, Hallensleben M, Heinemann FM, Hessler N, Hugo C, Kaufmann M, Kauke T, Koch M, Konig IR, Kurschat C, Lehmann C, Marget M, Muhlfeld A, Nitschke M, Pego da Silva L, Quick C, Rahmel A, Rath T, Reinke P, Renders L, Sommer F, Spriewald B, Staeck O, Stippel D, Susal C, Thiele B, Zecher D, Lachmann N (2019). Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study. Clin J Am Soc Nephrol, 14, 1056-1066.
     


    10. 2018


  10. Eder M, Schwarz C, Kammer M, Jacobsen N, Stavroula ML, Cowan MJ, Chongkrairatanakul T, Gaston R, Ravanan R, Ishida H, Bachmann A, Alvarez S, Koch M, Garrouste C, Duffner UA, Cullis B, Schaap N, Meding (2018). Allograft and patient survival after sequential HSCT and kidney transplantation from the same donor-A multicenter analysis. Am J Transplant, 13, 1-13.
     


    11. 2017


  11. Krasselt M, Pierer M, Amann K, Bachmann A, Lindner TH (2017). [Clinical Course of an Early Childhood-Onset Granulomatosis with Polyangiitis]. Dtsch Med Wochenschr, 142(12), 904-908.
     
  12. Kralisch S, Hoffmann A, Kloting N, Bachmann A, Kratzsch J, Stolzenburg JU, Dietel A, Beige J, Anders M, Bast I, Bluher M, Zhang MZ, Harris RC, Stumvoll M, Fasshauer M, Ebert T (2017). FSTL3 is increased in renal dysfunction. Nephrol Dial Transplant, 32(10), 1637-1644.
     
  13. Kralisch S, Hoffmann A, Kloting N, Bachmann A, Kratzsch J, Bluher M, Zhang MZ, Harris RC, Stumvoll M, Fasshauer M, Ebert T (2017). The novel adipokine/hepatokine fetuin B in severe human and murine diabetic kidney disease. Diabetes Metab, 43(5), 465-468.
     
  14. Munch J, Bachmann A, Grohmann M, Mayer C, Kirschfink M, Lindner TH, Bergmann C, Halbritter J (2017). Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies. Clin Kidney J, 10(6), 742-746.
     


    15. 2015


  15. Berger T, Kaiser T, Scholz M, Bachmann A, Ceglarek U, Hesse G, Hagemeyer B, Stumvoll M, Thiery J, Dietz A (2015). Fibrinogen is not a prognostic factor for response to HELP-apheresis in sudden sensorineural hearing loss (SSHL). Eur Arch Otorhinolaryngol, 272(12), 3693-3703.
     


    16. 2014


  16. Ebert T, Focke D, Petroff D, Wurst U, Richter J, Bachmann A, Lossner U, Kralisch S, Kratzsch J, Beige J, Bast I, Anders M, Bluher M, Stumvoll M, Fasshauer M (2014). Serum levels of the myokine irisin in relation to metabolic and renal function. Eur J Endocrinol, 170(4), 501-506.
     
  17. Hindricks J, Ebert T, Bachmann A, Kralisch S, Lossner U, Kratzsch J, Stolzenburg JU, Dietel A, Beige J, Anders M, Bast I, Bluher M, Stumvoll M, Fasshauer M (2014). Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction. Clin Endocrinol (Oxf), 80(6), 918-924.
     
  18. Ebert T, Hopf LM, Wurst U, Bachmann A, Kralisch S, Lossner U, Platz M, Kratzsch J, Stolzenburg JU, Dietel A, Grisk O, Beige J, Anders M, Bast I, Kloting N, Bluher M, Stumvoll M, Fasshauer M (2014). Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction. Nutr Metab Cardiovasc Dis, 24(9), 1027-1034.
     
  19. Ebert T, Kralisch S, Hoffmann A, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Tonjes A, Fasshauer M (2014). Circulating Angiopoietin-like Protein 8 Is Independently Associated With Fasting Plasma Glucose and Type 2 Diabetes Mellitus. J Clin Endocrinol Metab, 99(12), 2510-2517.
     
  20. Hau HM, Tautenhahn HM, Schmelzle M, Krenzien F, Schoenberg MB, Morgul MH, Uhlmann D, Wiltberger G, Rasche M, Bachmann A, Jonas S, Bartels M (2014). Management of urologic complications in renal transplantation: a single-center experience. Transplant Proc, 46(5), 1332-1339.
     


    21. 2013


  21. Richter J, Focke D, Ebert T, Kovacs P, Bachmann A, Lossner U, Kralisch S, Kratzsch J, Beige J, Anders M, Bast I, Bluher M, Stumvoll M, Fasshauer M (2013). Serum levels of the adipokine progranulin depend on renal function. Diabetes Care, 36(2), 410-414.
     
  22. Ponisch W, Moll B, Bourgeois M, Andrea M, Schliwa T, Heyn S, Schmalfeld M, Edelmann T, Becker C, Hoffmann FA, Schwarzer A, Kreibich U, Egert M, Stiegler R, Krahl R, Remane Y, Bachmann A, Lindner T, We (2013). Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure. J Cancer Res Clin Oncol, 139(11), 1937-1946.
     


    23. 2012


  23. Ponisch W, Andrea M, Wagner I, Hammerschmidt D, Kreibich U, Schwarzer A, Zehrfeld T, Schwarz M, Winkelmann C, Petros S, Bachmann A, Lindner T, Niederwieser D (2012). Successful treatment of patients with newly diagnosed/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone. J Cancer Res Clin Oncol, 138(8), 1405-1412.
     


    24. 2011


  24. Baranowski T, Kralisch S, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2011). Serum levels of the adipokine fasting-induced adipose factor/angiopoietin-like protein 4 depend on renal function. Horm Metab Res, 43(2), 117-120.
     
  25. Philipp A, Kralisch S, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2011). Serum levels of the adipokine zinc-α2-glycoprotein are increased in chronic hemodialysis. Metabolism, 60(5), 669-672.
     
  26. Fangmann J, Kathrin Al-Ali H, Sack U, Kamprad M, Tautenhahn HM, Faber S, Hauss J, Niederwieser D, Lindner T, Bachmann A (2011). Kidney transplant from the same donor without maintenance immunosuppression after previous hematopoietic stem cell transplant. Am J Transplant, 11(1), 156-162.
     
  27. Halbritter J, Mayer C, Bachmann A, Rasche FM, Uhlmann D, Stumvoll M, Lindner TH (2011). Successful simultaneous pancreas kidney transplantation in maturity-onset diabetes of the young type 5. Transplantation, 92(8), 45-47.
     
  28. Fangmann J, Kathrin Al-Ali H, Sack U, Kamprad M, Tautenhahn HM, Faber S, Hauss J, Niederwieser D, Lindner T, Bachmann A (2011). Kidney transplant from the same donor without maintenance immunosuppression after previous hematopoietic stem cell transplant. Am J Transplant, 11(1), 156-162.
     


    29. 2010


  29. Reiche M, Bachmann A, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2010). Fibroblast growth factor 19 serum levels: relation to renal function and metabolic parameters. Horm Metab Res, 42(3), 178-181.
     
  30. Pfau D, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2010). Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care, 33(1), 171-173.
     


    31. 2009


  31. Stein S, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2009). Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care, 32(1), 126-128.
     
  32. Ebert T, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2009). Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis. Metabolism, 58(4), 547-551.
     


    33. 2008


  33. Seeger J, Ziegelmeier M, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2008). Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab, 93(1), 247-251.
     
  34. Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2008). Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis. Metabolism, 57(10), 1414-1421.
     
  35. Sommer G, Ziegelmeier M, Bachmann A, Kralisch S, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2008). Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD). Clin Endocrinol (Oxf), 69(6), 901-905.
     
  36. Kralisch S, Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2008). Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease. Atherosclerosis, 199(2), 440-444.
     


    37. 2007


  37. Kreißig C, Bachmann A, Stumvoll M, Schröcke G (2007). PD Dr. med. habil. Harald Achenbach zum 65. Geburtstag Ärzteblatt Sachsen, 18(9), 480.
     
  38. Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M (2007). Serum levels of adipokine retinol-binding protein-4 in relation to renal function. Diabetes Care, 30(10), 2588-2592.
     


    39. 2006


  39. Hoffmeister A, Wittenburg H, Teich N, Bachmann A, Borte G, Mossner J, Achenbach H (2006). [A 32-year-old patient with diarrhoe and acute kidney failure.] Internist (Berl), 47(10), 1063-1067.
     


    40. 2004


  40. Thamer C, Haap M, Bachmann O, Zur Nieden T, Tschritter O, Stefan N, Fritsche A, Jacob S, Stumvoll M, Haring H (2004). Serum adiponectin levels predict the effect of short-term dietary interventions on insulin sensitivity in humans. Diabetologia, 47(7), 1303-1305.
     
  41. Thamer C, Machann J, Haap M, Bachmann O, Wietek B, Dahl D, Tschritter O, Fritsche A, Jacob S, Schick F, Stumvoll M, Haring H (2004). [Reduced insulin effect in subclinical fatty liver] Dtsch Med Wochenschr, 129(16), 872-875.